• 1
    Gershon RK, Kondo K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 1970;18:72337.
  • 2
    Gershon RK, Kondo K. Infectious immunological tolerance. Immunology 1971;21:90314.
  • 3
    Gershon RK, Cohen P, Hencin R, Liebhaber SA. Suppressor T cells. J Immunol 1972;108:58690.
  • 4
    Moller G. Do suppressor T cells exist? Scand J Immunol 1988;27:24750.
  • 5
    Sakaguchi S, Wing K, Miyara M. Regulatory T cells – a brief history and perspective. Eur J Immunol 2007;37 (Suppl. 1):S11623.
  • 6
    Sojka DK, Huang YH, Fowell DJ. Mechanisms of regulatory T-cell suppression – a diverse arsenal for a moving target. Immunology 2008;124:1322.
  • 7
    Tang Q, Bluestone JA. The Foxp3 +  regulatory T cell: a jack of all trades, master of regulation. Nat Immun 2008;9:23944.
  • 8
    Stockinger B, Barthlott T, Kassiotis G. T cell regulation: a special job or everyone’s responsibility? Nat Immun 2001;2:7578.
  • 9
    Zinkernagel RM. On cross-priming of MHC class I-specific CTL: rule or exception? Eur J Immunol 2002;32:238592.
  • 10
    Alpan O, Bachelder E, Isil E, Arnheiter H, Matzinger P. ‘Educated’ dendritic cells act as messengers from memory to naive T helper cells. Nat Immun 2004;5:61522.
  • 11
    Matzinger P. Friendly and dangerous signals: is the tissue in control? Nat Immun 2007;8:113.
  • 12
    Jankovic D, Kullberg MC, Feng CG et al. Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 2007;204:27383.
  • 13
    Cohn M. What roles do regulatory T cells play in the control of the adaptive immune response? Int Immunol 2008;20:110718.
  • 14
    Dembic Z. Beginning of the end of (understanding) the immune response. Scand J Immunol 2008;68:3812.
  • 15
    Cohn M. A reply to Dembic: on an end to the beginning of misunderstanding the immune response. Scand J Immunol 2009;69:3025.
  • 16
    Anderson CC. Placing regulatory T cells into global theories of immunity: an analysis of Cohn’s challenge to integrity (Dembic). Scand J Immunol 2009;69:3069.
  • 17
    Cohn M. On the critique by Colin Anderson of “A Reply to Dembic: On an end to the beginning of mis-understanding the immune response”. Scand J Immunol 2009;70:19.
  • 18
    Anderson CC. On the sorting of the repertoire: An analysis of Cohn’s challenge to integrity (Dembic), round 2. Scand J Immunol 2009; (in press).
  • 19
    Cohn M. A rationalized set of default postulates that permit a coherent description of the immune system amenable to computer modeling. Scand J Immunol 2008;68:37180.
  • 20
    Cunliffe J. Intentional pathogen killing – or denial of substrate? Scand J Immunol 2007;66:6049.
  • 21
    Nagy ZA. Evolutionary origin of the immune system: a dialogue with Rod Langman. Scand J Immunol 2008;67:31321.
  • 22
    Cunliffe J. A proliferation of pathogens through the 20th century. Scand J Immunol 2008;68:1208.
  • 23
    McGonagle D, Georgouli T. The importance of ‘Mechnikov’s thorn’ for an improved understanding of 21st century medicine and immunology: a view from the eye. Scand J Immunol 2008;68:12939.
  • 24
    Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:115164.
  • 25
    Wang R, Song L, Han G et al. Mechanisms of regulatory T-cell induction by antigen-IgG-transduced splenocytes. Scand J Immunol 2007;66:51522.
  • 26
    Piao WH, Jee YH, Liu RL et al. IL-21 modulates CD4 + CD25 +  regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis. Scand J Immunol 2008;67:3746.
  • 27
    Wang Y, Meng J, Wang X et al. Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients. Scand J Immunol 2008;67:6370.
  • 28
    Curotto de Lafaille MA, Muriglan S, Sunshine MJ et al. Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes. J Exp Med 2001;194:134959.
  • 29
    Akbari O, Freeman GJ, Meyer EH et al. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat Med 2002;8:102432.
  • 30
    Zuany-Amorim C, Sawicka E, Manlius C et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002;8:6259.
  • 31
    Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:123740.
  • 32
    Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997;18:33543.
  • 33
    Zhang X, Izikson L, Liu L, Weiner HL. Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration. J Immunol 2001;167:424553.
  • 34
    Karlsson MR, Rugtveit J, Brandtzaeg P. Allergen-responsive CD4 + CD25 +  regulatory T cells in children who have outgrown cow’s milk allergy. J Exp Med 2004;199:167988.
  • 35
    Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immun 2004;5:26671.
  • 36
    Asseman C, Fowler S, Powrie F. Control of experimental inflammatory bowel disease by regulatory T cells. Am J Respir Crit Care Med 2000;162:S1859.
  • 37
    Hori S, Carvalho TL, Demengeot J. CD25 + CD4 +  regulatory T cells suppress CD4 +  T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 2002;32:128291.
  • 38
    Kullberg MC, Jankovic D, Gorelick PL et al. Bacteria-triggered CD4(+) T regulatory cells suppress Helicobacter hepaticus-induced colitis. J Exp Med 2002;196:50515.
  • 39
    Baecher-Allan C, Viglietta V, Hafler DA. Inhibition of human CD4(+)CD25(+high) regulatory T cell function. J Immunol 2002;169:62107.
  • 40
    Oldenhove G, De Heusch M, Urbain-Vansanten G et al. CD4 +  CD25 +  regulatory T cells control T helper cell type 1 responses to foreign antigens induced by mature dendritic cells in vivo. J Exp Med 2003;198:25966.
  • 41
    McNeill A, Spittle E, Backstrom BT. Partial depletion of CD69low-expressing natural regulatory T cells with the anti-CD25 monoclonal antibody PC61. Scand J Immunol 2007;65:639.
  • 42
    Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 2000;192:295302.
  • 43
    Takahashi T, Tagami T, Yamazaki S et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000;192:30310.
  • 44
    McHugh RS, Whitters MJ, Piccirillo CA et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002;16:31123.
  • 45
    Huang CT, Workman CJ, Flies D et al. Role of LAG-3 in regulatory T cells. Immunity 2004;21:50313.
  • 46
    Seddiki N, Santner-Nanan B, Martinson J et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006;203:1693700.
  • 47
    Liu W, Putnam AL, Xu-Yu Z et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4 +  T reg cells. J Exp Med 2006;203:170111.
  • 48
    Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:105761.
  • 49
    Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 + CD25 +  regulatory T cells. Nat Immun 2003;4:3306.
  • 50
    Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4 + CD25 +  T regulatory cells. Nat Immun 2003;4:33742.
  • 51
    Robb RJ, Munck A, Smith KA. T cell growth factor receptors. Quantitation, specificity, and biological relevance. J Exp Med 1981;154:145574.
  • 52
    Yamazaki S, Iyoda T, Tarbell K et al. Direct expansion of functional CD25 +  CD4 +  regulatory T cells by antigen-processing dendritic cells. J Exp Med 2003;198:23547.
  • 53
    Allan SE, Crome SQ, Crellin NK et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007;19:34554.
  • 54
    Walunas TL, Lenschow DJ, Bakker CY et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994;1:40513.
  • 55
    Nocentini G, Giunchi L, Ronchetti S et al. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc Natl Acad Sci USA 1997;94:621621.
  • 56
    Triebel F, Jitsukawa S, Baixeras E et al. LAG-3, a novel lymphocyte activation gene closely related to CD4. J Exp Med 1990;171:1393405.
  • 57
    Baixeras E, Huard B, Miossec C et al. Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens. J Exp Med 1992;176:32737.
  • 58
    Aerts NE, Dombrecht EJ, Ebo DG, Bridts CH, Stevens WJ, De Clerck LS. Activated T cells complicate the identification of regulatory T cells in rheumatoid arthritis. Cell Immunol 2008;251:10915.
  • 59
    Lim HW, Kim CH. Loss of IL-7 receptor alpha on CD4 +  T cells defines terminally differentiated B cell-helping effector T cells in a B cell-rich lymphoid tissue. J Immunol 2007;179:744856.
  • 60
    Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005;22:32941.
  • 61
    Morgan ME, Van Bilsen JH, Bakker AM et al. Expression of FOXP3 mRNA is not confined to CD4 + CD25 +  T regulatory cells in humans. Hum Immunol 2005;66:1320.
  • 62
    Roncador G, Brown PJ, Maestre L et al. Analysis of FOXP3 protein expression in human CD4 + CD25 +  regulatory T cells at the single-cell level. Eur J Immunol 2005;35:168191.
  • 63
    Wang J, Ioan-Facsinay A, Van Der Voort EI, Huizinga TW, Toes RE. Transient expression of FOXP3 in human activated nonregulatory CD4 +  T cells. Eur J Immunol 2007;37:12938.
  • 64
    Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4 + FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007;110:298390.
  • 65
    Pillai V, Ortega SB, Wang CK, Karandikar NJ. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol 2007;123:1829.
  • 66
    Thornton AM, Shevach EM. CD4 + CD25 +  immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:28796.
  • 67
    Takahashi T, Kuniyasu Y, Toda M et al. Immunologic self-tolerance maintained by CD25 + CD4 +  naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998;10:196980.
  • 68
    Szymczak-Workman AL, Workman CJ, Vignali DA. Cutting edge: regulatory T cells do not require stimulation through their TCR to suppress. J Immunol 2009;182:518892.
  • 69
    Hori S, Haury M, Coutinho A, Demengeot J. Specificity requirements for selection and effector functions of CD25 + 4 +  regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc Natl Acad Sci USA 2002;99:82138.
  • 70
    Tang Q, Henriksen KJ, Bi M et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004;199:145565.
  • 71
    Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM. CD25 +  CD4 +  T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004;199:146777.
  • 72
    Tonkin DR, He J, Barbour G, Haskins K. Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo. J Immunol 2008;181:451622.
  • 73
    Huter EN, Stummvoll GH, DiPaolo RJ, Glass DD, Shevach EM. Cutting edge: antigen-specific TGF beta-induced regulatory T cells suppress Th17-mediated autoimmune disease. J Immunol 2008; 181:820913.
  • 74
    Homann D, Holz A, Bot A et al. Autoreactive CD4 +  T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity 1999;11:46372.
  • 75
    Yu P, Gregg RK, Bell JJ et al. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. J Immunol 2005;174:677280.
  • 76
    Tanchot C, Vasseur F, Pontoux C, Garcia C, Sarukhan A. Immune regulation by self-reactive T cells is antigen specific. J Immunol 2004;172:428591.
  • 77
    Tang Q, Adams JY, Tooley AJ et al. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immun 2006;7:8392.
  • 78
    Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987;49:27380.
  • 79
    Blackman MA, Gerhard-Burgert H, Woodland DL, Palmer E, Kappler JW, Marrack P. A role for clonal inactivation in T cell tolerance to Mls-1a. Nature 1990;345:5402.
  • 80
    McGuirk P, McCann C, Mills KH. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 2002;195:22131.
  • 81
    Montagnoli C, Bacci A, Bozza S et al. B7/CD28-dependent CD4 + CD25 +  regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J Immunol 2002;169:6298308.
  • 82
    Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4 + CD25 +  regulatory T cells control Leishmania major persistence and immunity. Nature 2002;420:5027.
  • 83
    Suffia IJ, Reckling SK, Piccirillo CA, Goldszmid RS, Belkaid Y. Infected site-restricted Foxp3 +  natural regulatory T cells are specific for microbial antigens. J Exp Med 2006;203:77788.
  • 84
    Van Maurik A, Herber M, Wood KJ, Jones ND. Cutting edge: CD4 + CD25 +  alloantigen-specific immunoregulatory cells that can prevent CD8 +  T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol 2002;169:54014.
  • 85
    Ochando JC, Yopp AC, Yang Y et al. Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3 +  regulatory T cells. J Immunol 2005;174:69937005.
  • 86
    Jordan MS, Boesteanu A, Reed AJ et al. Thymic selection of CD4 + CD25 +  regulatory T cells induced by an agonist self-peptide. Nat Immun 2001;2:3016.
  • 87
    Kawahata K, Misaki Y, Yamauchi M et al. Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J Immunol 2002;168:4399405.
  • 88
    Apostolou I, Sarukhan A, Klein L, Von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immun 2002;3:75663.
  • 89
    Van Santen HM, Benoist C, Mathis D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J Exp Med 2004;200:122130.
  • 90
    Hsieh CS, Liang Y, Tyznik AJ, Self SG, Liggitt D, Rudensky AY. Recognition of the peripheral self by naturally arising CD25 +  CD4 +  T cell receptors. Immunity 2004;21:26777.
  • 91
    Hsieh CS, Zheng Y, Liang Y, Fontenot JD, Rudensky AY. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat Immun 2006;7:40110.
  • 92
    Wong J, Obst R, Correia-Neves M, Losyev G, Mathis D, Benoist C. Adaptation of TCR repertoires to self-peptides in regulatory and nonregulatory CD4 +  T cells. J Immunol 2007;178:703241.
  • 93
    Pacholczyk R, Kern J, Singh N, Iwashima M, Kraj P, Ignatowicz L. Nonself-antigens are the cognate specificities of Foxp3 +  regulatory T cells. Immunity 2007;27:493504.
  • 94
    Stephens GL, Shevach EM. Foxp3 +  regulatory T cells: selfishness under scrutiny. Immunity 2007;27:4179.
  • 95
    Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:234857.
  • 96
    Harrington LE, Hatton RD, Mangan PR et al. Interleukin 17-producing CD4 +  effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immun 2005;6:112332.
  • 97
    Park H, Li Z, Yang XO et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immun 2005;6:113341.
  • 98
    Nurieva RI, Chung Y, Hwang D et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008;29:13849.
  • 99
    Vogelzang A, McGuire HM, Yu D, Sprent J, Mackay CR, King C. A fundamental role for interleukin-21 in the generation of T follicular helper cells. Immunity 2008;29:12737.
  • 100
    Gajewski TF, Fitch FW. Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J Immunol 1988;140:424552.
  • 101
    Fernandez-Botran R, Sanders VM, Mosmann TR, Vitetta ES. Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells. J Exp Med 1988;168:54358.
  • 102
    Swain SL, Weinberg AD, English M, Huston G. IL-4 directs the development of Th2-like helper effectors. J Immunol 1990;145:3796806.
  • 103
    Brinkmann V, Geiger T, Alkan S, Heusser CH. Interferon alpha increases the frequency of interferon gamma-producing human CD4 +  T cells. J Exp Med 1993;178:165563.
  • 104
    O’Connor W Jr, Kamanaka M, Booth CJ et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immun 2009;10:6039.
  • 105
    Wurster AL, Rodgers VL, Satoskar AR et al. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J Exp Med 2002;196:96977.
  • 106
    Yssel H, De Waal Malefyt R, Roncarolo MG et al. IL-10 is produced by subsets of human CD4 +  T cell clones and peripheral blood T cells. J Immunol 1992;149:237884.
  • 107
    Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993;150:35360.
  • 108
    Assenmacher M, Schmitz J, Radbruch A. Flow cytometric determination of cytokines in activated murine T helper lymphocytes: expression of interleukin-10 in interferon-gamma and in interleukin-4-expressing cells. Eur J Immunol 1994;24:1097101.
  • 109
    Anderson CF, Oukka M, Kuchroo VJ, Sacks D. CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 2007;204:28597.
  • 110
    Sun J, Madan R, Karp CL, Braciale TJ. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med 2009;15:27784.
  • 111
    Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4 +  T cells. J Exp Med 1996;183:266974.
  • 112
    Coffman RL, Lebman DA, Shrader B. Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med 1989;170:103944.
  • 113
    Sonoda E, Matsumoto R, Hitoshi Y et al. Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J Exp Med 1989;170:141520.
  • 114
    Van Vlasselaer P, Punnonen J, De Vries JE. Transforming growth factor-beta directs IgA switching in human B cells. J Immunol 1992;148:20627.
  • 115
    McIntyre TM, Klinman DR, Rothman P et al. Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells. J Exp Med 1993;177:10317.
  • 116
    Satoguina JS, Adjobimey T, Arndts K et al. Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta. Eur J Immunol 2008;38:310113.
  • 117
    Voo KS, Wang YH, Santori FR et al. Identification of IL-17-producing FOXP3 +  regulatory T cells in humans. Proc Natl Acad Sci U S A 2009;106:47938.
  • 118
    Beriou G, Costantino CM, Ashley CW et al. IL-17-producing human peripheral regulatory T cells retain suppressive function. Blood 2009;113:42409.
  • 119
    Ayyoub M, Deknuydt F, Raimbaud I et al. Human memory FOXP3 +  Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proc Natl Acad Sci U S A 2009;106:863540.
  • 120
    Brunkow ME, Jeffery EW, Hjerrild KA et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001;27:6873.
  • 121
    Wan YY, Flavell RA. Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci U S A 2005;102:512631.
  • 122
    Chatila TA, Blaeser F, Ho N et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000;106:R7581.
  • 123
    Wildin RS, Ramsdell F, Peake J et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001;27:1820.
  • 124
    Bennett CL, Christie J, Ramsdell F et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001;27:201.
  • 125
    Tivol EA, Borriello F, Schweitzer AN, Lynch WP, Bluestone JA, Sharpe AH. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 1995;3:5417.
  • 126
    Waterhouse P, Penninger JM, Timms E et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995;270:9858.
  • 127
    Shull MM, Ormsby I, Kier AB et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992;359:6939.
  • 128
    Li MO, Sanjabi S, Flavell RA. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006;25:45571.
  • 129
    Hori S. Rethinking the molecular definition of regulatory T cells. Eur J Immunol 2008;38:92830.
  • 130
    Gavin MA, Rasmussen JP, Fontenot JD et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007;445:7715.
  • 131
    Lin W, Haribhai D, Relland LM et al. Regulatory T cell development in the absence of functional Foxp3. Nat Immun 2007;8:35968.
  • 132
    Hill JA, Feuerer M, Tash K et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 2007;27:786800.
  • 133
    Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immun 2007;8:27784.
  • 134
    Floess S, Freyer J, Siewert C et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 2007;5:e38.
  • 135
    Baron U, Floess S, Wieczorek G et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 2007;37:237889.
  • 136
    Polansky JK, Kretschmer K, Freyer J et al. DNA methylation controls Foxp3 gene expression. Eur J Immunol 2008;38:165463.
  • 137
    Schubert LA, Jeffery E, Zhang Y, Ramsdell F, Ziegler SF. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 2001;276:376729.
  • 138
    Marson A, Kretschmer K, Frampton GM et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 2007;445:9315.
  • 139
    Zheng Y, Josefowicz SZ, Kas A, Chu TT, Gavin MA, Rudensky AY. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007;445:93640.
  • 140
    Chen TC, Cobbold SP, Fairchild PJ, Waldmann H. Generation of anergic and regulatory T cells following prolonged exposure to a harmless antigen. J Immunol 2004;172:59007.
  • 141
    Groux H, O’Garra A, Bigler M et al. A CD4 +  T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:73742.
  • 142
    Vieira PL, Christensen JR, Minaee S et al. IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4 + CD25 +  regulatory T cells. J Immunol 2004;172:598693.
  • 143
    Levings MK, Gregori S, Tresoldi E, Cazzaniga S, Bonini C, Roncarolo MG. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25 + CD4 +  Tr cells. Blood 2005;105:11629.
  • 144
    Han Y, Guo Q, Zhang M, Chen Z, Cao X. CD69 +  CD4 +  CD25- T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1. J Immunol 2009;182:11120.
  • 145
    Lund JM, Hsing L, Pham TT, Rudensky AY. Coordination of early protective immunity to viral infection by regulatory T cells. Science 2008;320:12204.
  • 146
    Komatsu N, Mariotti-Ferrandiz ME, Wang Y, Malissen B, Waldmann H, Hori S. Heterogeneity of natural Foxp3 +  T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci U S A 2009;106:19038.
  • 147
    Tsuji M, Komatsu N, Kawamoto S et al. Preferential generation of follicular B helper T cells from Foxp3 +  T cells in gut Peyer’s patches. Science 2009;323:148892.
  • 148
    Duarte JH, Zelenay S, Bergman ML, Martins AC, Demengeot J. Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur J Immunol 2009;39:94855.
  • 149
    Wei G, Wei L, Zhu J et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4 +  T cells. Immunity 2009;30:15567.
  • 150
    Xu L, Kitani A, Fuss I, Strober W. Cutting edge: regulatory T cells induce CD4 + CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 2007;178:67259.
  • 151
    Yang XO, Nurieva R, Martinez GJ et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008;29:4456.
  • 152
    Zhou L, Lopes JE, Chong MM et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008;453:23640.
  • 153
    Osorio F, LeibundGut-Landmann S, Lochner M et al. DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol 2008;38:327481.
  • 154
    Leon K, Perez R, Lage A, Carneiro J. Modelling T-cell-mediated suppression dependent on interactions in multicellular conjugates. J Theor Biol 2000;207:23154.
  • 155
    Carneiro J, Leon K, Caramalho I et al. When three is not a crowd: a Crossregulation model of the dynamics and repertoire selection of regulatory CD4 +  T cells. Immunol Rev 2007;216:4868.
  • 156
    Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4 + CD25 +  T cell-mediated suppression by dendritic cells. Science 2003;299:10336.
  • 157
    Sutmuller RP, Den Brok MH, Kramer M et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006;116:48594.
  • 158
    Jonsson R, Ljunggren HG, Natvig JB, Orn A. Goran Moller 1936–2008. Scand J Immunol 2008;68:113.
  • 159
    Coutinho A, Holmberg D. Goran Moller 1936–2008. Scand J Immunol 2008;68:1147.